Anthony Fauci, the federal government’s top infectious disease expert, is putting himself in “modified quarantine” after possibly being exposed to a White House staffer with coronavirus, CNN reported Saturday.Fauci, 79, told CNN correspondent Jake Tapper that the contact was “low risk” — meaning he did not have direct contact with the sick staffer.A test Friday found Fauci did not have COVID-19, CNN reported.Fauci plans to be tested every day, and will work from home wearing a mask, the network said. Fauci might eventually go to his office at the National Institute of Allergies and Infectious ...
The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech Covid-19 vaccine on children aged 12 to 15 years old.
Acting FDA commissioner Janet Woodcock described the move as a "significant step in the fight against the Covid-19 pandemic."
"Today's action allows for a younger population to be protected from Covid-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic," Woodcock said in a statement.
"Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our Covid-19 vaccine emergency use authorizations," she added.
The FDA previously granted an emergency use authorization for the Pfizer-BioNTech vaccine to individuals aged 16 and older.
"Having a vaccine authorized for a younger population is a critical step in continuing to lessen the immense public health burden caused by the Covid-19 pandemic," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
The FDA said some 1.5 million Covid-19 cases in individuals aged 11 to 17 years old have been reported to the Centers for Disease Control and Prevention between March 1, 2020 through April 30, 2021.
The course of the disease is generally milder in children but they can pass it on to older, more vulnerable adults.
Rep. Marjorie Taylor Greene (R-GA) is not ready to rally behind Rep. Elise Stefanik (R-NY) to replace Rep. Liz Cheney (R-WY) as the number three Republican in the House of Representatives.
"On Wednesday, our GOP Conference will be voting to remove Liz Cheney from the chair," Greene wrote about the vote that Cheney is widely expected to lose.
"Currently, we only have one member running for chair," she noted, referring to Stefanik.
"I want a break before we vote on a replacement. Options are good and so are conservative votes," she wrote.
Some conservatives have been frustrated the prospect of replacing Cheney with a less-conservative member.
On Wednesday, our GOP Conference will be voting to remove Liz Cheney from the chair. A vote some of us already too… https://t.co/JefTojsJp1— Marjorie Taylor Greene 🇺🇸 (@Marjorie Taylor Greene 🇺🇸)1620684023.0
The World Health Organization on Monday classified a coronavirus mutation first detected in India as a "variant of concern" for global health, warning that it appears to be more contagious than other strains.
Experts believe the variant, formally known as B.1.617, could be a key driving force behind the devastating coronavirus surge in India, which has been reporting more than 300,000 new infections daily over the past two weeks as the nation's vaccination program is hampered by shortages that could last months.
Maria Van Kerkhove, the WHO's technical lead for Covid-19, said during a press conference that while "we need much more information about this virus variant," preliminary studies of the mutation have demonstrated "increased transmissibility."
On Twitter, WHO chief scientist Soumya Swaminathan stressed that there is not yet enough information to determine whether the strain is able to evade vaccines or therapeutics and said her organization will be "updating variant data continuously."
"The pattern now is that one person in the family gets it, the whole family seems to get it," Swaminathan told the Wall Street Journal on Monday. "This is unlike the first wave. And so I think what we're seeing is more transmissible."
The WHO's reclassification of B.1.617—which was previously labeled a "variant of interest"—came as experts and progressive campaigners continue to warn that people across the globe will remain in danger as long as public health measures are flouted and the coronavirus is allowed to spread uncontrolled among populations without access to vaccines.
"With Africa accounting for only around 2% of global coronavirus vaccinations, health officials on the continent are looking warily at waves of infections sweeping India and elsewhere that have stoked fears of a long tail end of the pandemic," the Washington Post reported Sunday. "Current timelines for mass vaccination campaigns in most African countries run well into next year—if not further."
In late March, epidemiologists from dozens of countries said they believe the international community has "a year or less" before coronavirus variants spread widely enough to render a majority of first-generation vaccines ineffective—a nightmare scenario for the world and a major profit opportunity for the pharmaceutical industry.
"With millions of people around the world infected with this virus, new mutations arise every day," Gregg Gonsalves, associate professor of epidemiology at Yale University, said in March. "Unless we vaccinate the world, we leave the playing field open to more and more mutations, which could churn out variants that could evade our current vaccines and require booster shots to deal with them."
Don't Sit on the Sidelines of History. Join Raw Story Investigates and Go Ad-Free. Support Honest Journalism.
$95 / year — Just $7.91/month
I want to Support More
$14.99 per month